A study of oxidative stress and influence of antioxidant vitamins supplementation in patients with major depression

Current Neurobiology

Volumn 3, Issue 2, 2012, Pages 107-111

  Ghodake, Santoshi R ^a   Suryakar, Adinath N ^b   Kulhalli, Prabhakar M ^b   Padalkar, Ramchandra K ^a   Shaikh, Abdul Kayyum ^c  

^a PDVVPF's College of Pharmacy   (India)

^b MAHARASHTRA UNIVERSITY OF HEALTH SCIENCES   (India)

^c Ashwini Rural Medical College and Hospital   (India)

Author keywords

Lipid peroxidation; Major depression (MD); Malondialdehyde (MDA); Oxidative stress; Total antioxidant capacity (TAC)

Indexed keywords

ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; ASCORBIC ACID; MALONALDEHYDE; NITRATE; NITRITE; SUPEROXIDE DISMUTASE; URIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; ENZYME ASSAY; HUMAN; LIPID PEROXIDATION; MAJOR DEPRESSION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PATIENT ASSESSMENT; REMISSION; VITAMIN SUPPLEMENTATION;

EID: 84875243425     PISSN: 09759042     EISSN: 09761705     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Singh OP, Chakraborty I, Dasgupta A, Datta S. A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia. Indian J Psychiatry 2008; 50: 171-177.
2. Yao JK, Reddy RD, van Kammen DP. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 2001; 15:287-310.
3. Bilici M, Efe H, Koroglu A, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64: 43-51.
4. Khanzode SD, Dakhale G.N, Khanzode SS, Saoji A, Palasodkar R: Oxidative damage and major depression: the potential antioxidant action of selective serotonin reuptake inhibitors. Redox Rep, 2003; 8: 365-370.
5. Sarandol A, Sarandol E, Eker S, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative system. Hum Psychopharmacol 2007; 22: 67-73.
6. Selley ML: Increased (E)-4-hydroxy-2-nonenel and asymmetric dimethylarginine concentration and decreased nitric oxide concentration in the plasma of patients with major depression. J Affect Disord 2004; 80, 249-256.
7. Maes M, Vos N, Pioli R, Demedts P, Wauters A, Neels H, Christophe A: Lower serum vitamin E concentration in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 2000; 58: 241-146.
8. Owen AJ, BatterhamMJ, Probst YC, Grenyer BF, Tapsell LC. Low plasma vitamin E levels in major depression: diet or disease? Eur Jof Clin Nutr 2005; 59, 304-306.
9. Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Seth PK, Srimal R, Dikshit M: A study of nitric oxide, beta-adrenergic receptor and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. J Affect Disord 2002; 72: 45-52.
10. Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, Kap O, Yumru M, Savas HA, Akyol O. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Archives of MedicalResearch 2007; 38: 247-252.
11. Yanik M, Erel O, Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 2004a; 16: 200-203.
12. Yao JK, Reddy R, McElhinny LG, van Kammen DP. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J. Psychiatr. Res 1998a; 32: 385-391.
13. The ICD- 10. Classification of Mental and Behavioral Disorders: Clinical Description and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
14. Dodge JF, Mitchell G, Hanahan DJ. The preparation and chemical characterization of hemoglobin free ghosts of human red blood cells. Arch Biochem Biophys 1968; 110: 119-130.
15. Quist EH. Regulation of erythrocyte membrane shape by calcium ion. Biochem Biophys Res Commun 1980; 92: 631-637.
16. Kajari Das. A modified spectrophotometric assay of superoxide dismutase using nitrate formation by superoxide radicals. Indian J Biochem and Biophys 2000; 57: 201-4.
17. rd edition. WB Saunders Co. 1999; 1652-1653.
18. th edition 1988; 902.
19. Caraway WT. carbohydrates in Tietz N. W. (Ed). Fundamentals of clinical chemistry. W.B. Saunder Company; 173-176.
20. Bird RP, Draper HH. Comparative study on different methods of MDA determination. Methods Enzymol 1984; 105.
21. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium - reduction method. Clin Chem 1990; 36 (8): 1440-1443.
22. Benzie I, strain J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant Power": The FRAP Assay. Analytical Biochemistry 1996; 239(1): 70-76.
23. Forlenza MJ, Miller GE. Increased serum levels of 8- hydroxy-2'-deoxyguanosine in clinical depression. Psychosomatic Medicine 2006; 68: 1-7.
24. Gatecki P, Smemraj J, Bienikewicz M, Florkowski A, Gatecka E. lipid peroxidation and antioxidant protection in patients during acute depressive episodes and remission after fluoxetine treatment. Phramacollogical Reportr 2009; 61: 436-47.
25. Suzuki E, YAgi G, Nakaki T, Kanba S and Asai M. elevated plasma nitrate levels in depressive states. J Affect Disord 2001; 63: 221-224.
26. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002; 20: 171-175.
27. Kumari R, Chatterjee M, Singh S, Kundal M, Ashwalayan VD. Oxidative stree: A novel treatment target in psychiatric disorder. International J Pharmaceutical Sciences and Research. 2011; 9(1):165-72.
28. Janero DR. Malondialdehyde and thiobarbituric acid reactivity as diagnostic indices of lipid peroxidation and peroxidative injury. Free Radic Biol Med 1990; 9: 515-40.
29. Path, J. Cellular functions of ascorbic acid. Biochemistry and Cell Biology 1990; 6: 1166-73.
30. Nikolaus M, Hildegard S, Volker A et al. Severe tardive dyskinesia in affective disorders: Treatment with vitamin E and C. Neuropsychobiology 2002; 46 (suppl 1): 28-30.
31. Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F (2000). Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clinical Chemistry and Laboratory Medicine 2000; 38: 1277-1281.
32. Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Research 2003a; 62: 195-204.
33. Hamer, Mark, Bates, Christopher J, Mishra, Gita D. Depression, Physical Function, and Risk of Mortality: National Diet and Nutrition Survey in Adults Older Than 65 Years. American Journal of Geriatric Psychiatry 2011; 19(1):72-78.